Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer
Saman Farahmand, Aileen I. Fernandez, Fahad Ahmed, David L. Rimm, Jeffrey H. Chuang, Emily Reisenbichler, Kourosh Zarringhalam
Topics & Concepts
TrastuzumabBreast cancerMedicineH&E stainOncologyClassifier (UML)Internal medicineArtificial intelligenceImmunohistochemistryPathologyMachine learningCancerComputer scienceAI in cancer detectionHER2/EGFR in Cancer ResearchRadiomics and Machine Learning in Medical Imaging